ESR1 and breast cancer: Since it was evident the binding of estrogen and ERα could result in increased proliferation of normal and cancerous breast epithelial cells (Ali & Coombes, 2000; Russo & Russo, 2006), it is possible that rs2046210 polymorphism may alter the expression level of ESR1 and consequentially influence individual susceptibility to BC.